NLS Pharmaceutics AG carries a market capitalization of 919,601.00, placing it among publicly traded companies globally.
| Market Cap | 919,601.00 |
| Enterprise Value | N/A |
NLS Pharmaceutics AG's stock has declined approximately -85.94203% over the past 52 weeks. The 50-day moving average sits at 18.99, while the 200-day moving average is 19.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.94203% |
| 50-Day Moving Average | 18.99 |
| 200-Day Moving Average | 19.40 |
| Average Volume (20 Days) | N/A |
NLS Pharmaceutics AG's most recent stock split took place on October 31, 2025 with a 10:1 split ratio.
| Last Split Date | 10/31/2025 |
| Split Ratio | 10:1 |